References
- WHO Global Tuberculosis Report, 2014. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf [last accessed 27 Jun 2016].
- Tiwari R, Moraski GC, Krchnak V, et al. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents. J Am Chem Soc 2013;135:3539–49.
- Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–81.
- Mahapatra DK, Bharti SK, Asati V. Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives. Eur J Med Chem 2015;11:496–524.
- Hagmann KW. The many roles for fluorine in medicinal chemistry. J Med Chem 2015;51:4359–69.
- Ojima I. Use of fluorine in the medicinal chemistry and chemical biology of bioactive compounds-a case study on fluorinated taxane anticancer agents. ChemBioChem 2004;5:628–35.
- Yerien DE, Bonesi S, Postigo A. Fluorination methods in drug discovery. Org. Biomol. Chem 2016;14:8398–427.
- Prasad YR, Rao AL, Rambabu R. Synthesis and antimicrobial activity of some chalcone derivatives. E-J Chem 2008;5: 461–6.
- Lopez SN, Castelli MV, Zacchino SA, et al. In vitro antifungal evaluation and structure–activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 2001;9:1999–2013.
- Patel BB, Baviskar SB, Khadabadi S, Shiradkar SM. Design and synthesis of some novel chalcones as potent antimicrobial agent. Asian J Res Chem 2008;1:67–9.
- Burmaoglu S, Algul O, Anıl DA, et al. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Bioorg Med Chem Lett 2016;26:3172–6.
- National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes: Approved Standard NCCLS Document M24-A. Wayne, Pennsylvania; 2003.
- Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). Antimycobacterial Susceptibility Testing for M. tuberculosis: Tentative Standard NCCLS Document M24-T. Villanova, Pennsylvania; 2002.
- Woods GL, Washington JA, Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology; 1995:1327–41.
- Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: general principles and contemporary practice. Clin Infect Dis 1998;26:973–80.
- Friis-Moller A, Chen M, Fuursted K, et al. In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med 2002;68:416–19.
- Mata R, Morales I, Perez O, et al. Antimycobacterial compounds from piper sanctum. J Nat Prod 2004;67:1961–8.